Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.50
Bid: 64.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 3.00 (4.688%)
Open: 66.00
High: 66.00
Low: 65.50
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appt and Bank Funding

14 Feb 2007 07:01

Torex Retail PLC14 February 2007 Torex Retail plc (the "Company") Appointment of New Chairman and Increased Bank Funding Torex Retail plc, a leading global retail systems provider, today provides afurther update as to its board composition and financing arrangements. The Company announces that Steve Marshall has been appointed to the main Boardwith immediate effect as Non-executive Chairman. Mr Marshall has had aprestigious career in industry, including as CEO of both Railtrack PLC and ThornPLC, having also been group finance director at both companies. He is currentlynon-executive chairman of Delta PLC and a non-executive director of BalfourBeatty PLC and Southern Water Services Ltd. He was also executive chairman ofQueens Moat Houses PLC. This appointment follows those recently of Keith Taylor as Acting ChiefExecutive Officer and Iain Lynam as Chief Restructuring Officer, all of whichconsiderably strengthen the Board's operational and corporate restructuringexperience. The Company also announces that its syndicate of banks has agreed to provide therequested additional short-term working capital facility of £15.0 million. TheBoard considers that this will be sufficient to meet the Company's short-termworking capital requirements. The £15.0 million is in addition to the Company'sexisting total banking facilities of £152.5 million comprising term loans andoverdraft facilities. The Company expects to enter into further discussions with its bankers withrespect to its medium to long term financing requirements in the next fewmonths, when the Company has finalised results for the financial year ended 31December 2006 and has an up to date view of the 2007/2008 trading prospects. The Board is very pleased that it has concluded discussions with the Company'slenders with respect to its short-term financing requirements and that theCompany's lenders remain supportive. The Board is also delighted to haveappointed somebody of the calibre of Steve Marshall, whose experience andguidance will be of great benefit to the Company during this period. - Ends - Enquiries: Keith Taylor Acting CEO, Torex Retail plc Tel: 0870 300 6061 Ginny Pulbrook / Seb Hoyle / Lucie Holloway Citigate Dewe Rogerson Tel: 020 7638 9571 Additional details are set out below: Steve Marshall (age 50) Present directorships or partnerships: Delta PLC, Balfour Beatty PLC, SouthernWater Services Ltd Directorships or partnerships in previous five years: Queens Moat Houses PLC,Railtrack Group PLC Details of companies entering insolvency whilst a director or within 12 monthsof resignation: RT Group Holdings Ltd No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies. There is nothing further to disclose in relation to their appointment pursuantto Rule 17 of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Feb 20137:00 amRNSSuccessful safety study of dCELL® Meniscus
11th Feb 20132:57 pmRNSDirectorate Change
9th Jan 20137:15 amRNSHolding(s) in Company
30th Nov 201211:21 amRNSTissue Regenix board changes
26th Nov 20127:00 amRNSSets up US subsidiary
19th Nov 20127:00 amRNSAdds new patent global licence portfolio
4th Oct 20127:00 amRNSInterim data from clinical trial of dCELL® Dermis
4th Oct 20127:00 amRNSHalf Yearly Report
1st Oct 201210:57 amRNSTissue Regenix - senior development appointment
28th Sep 20123:30 pmRNSNotice of Results
7th Sep 20127:00 amRNSdCELL(R) vascular patch is safe and effective
2nd Aug 20122:31 pmRNSTissue Regenix makes appointment to Cardiac team
31st Jul 20123:02 pmRNSDirector/PDMR Shareholding
19th Jun 20122:39 pmRNSHolding(s) in Company
14th Jun 20127:00 amRNSResearch Update
11th Jun 201212:35 pmRNSResult of AGM
25th May 20127:00 amRNSExpands scope of development activities with NHSBT
10th May 20127:00 amRNSFinal Results
19th Apr 20121:49 pmRNSPoster shown at SAWC
16th Apr 20123:18 pmRNSNotice of Results
7th Feb 20124:00 pmRNSIssue of Equity and Total Voting Rights
11th Jan 201211:36 amRNSHolding(s) in Company
6th Jan 20125:05 pmRNSHolding(s) in Company
3rd Jan 20125:45 pmRNSHolding(s) in Company
3rd Jan 20125:43 pmRNSHolding(s) in Company
3rd Jan 20128:49 amRNSHolding(s) in Company
28th Dec 201112:00 pmRNSResult of General Meeting
8th Dec 201112:53 pmRNSIssue of Equity
25th Nov 20112:23 pmRNSUniversity Partner wins Queen's Anniversary Prize
4th Nov 20112:16 pmRNSHolding(s) in Company
14th Oct 20112:33 pmRNSHolding(s) in Company
10th Oct 20117:00 amRNSHalf Yearly Report
26th Jul 201111:04 amRNSIssue of Equity
7th Jul 20113:52 pmRNSIssue of Share Options
5th Jul 20111:30 pmRNSIssue of Equity
22nd Jun 20118:35 amRNSReceives EUR280,000 Grant Funding
13th Jun 20117:00 amRNSDirectorate Appointment
3rd Jun 201110:02 amRNSAGM Statement
11th May 20117:00 amRNSPositive Results in Clinical Evaluation of dCELL
4th May 20117:00 amRNSFinal Results
21st Apr 20117:00 amRNSTissue Regenix enters commercialisation agreement
29th Mar 20117:00 amRNSDirectorate Change
10th Mar 20117:00 amRNSNotice of allowance of patent received
4th Jan 201111:27 amRNSHolding(s) in Company
30th Dec 20109:05 amRNSHolding(s) in Company
23rd Dec 201012:44 pmRNSChange of Adviser
21st Dec 201010:12 amRNSAdviser - Change of Name
16th Dec 20107:00 amRNSResearch Update
10th Dec 20109:20 amRNSChange of Adviser
26th Nov 20103:12 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.